This inventor holds 2 USPTO granted patents and 2 published patent applications and 6 EPO patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ben Paul Whittaker: Innovator in Pharmaceutical Research
Introduction: Ben Paul Whittaker is an inventor based in Parma, Italy. He is currently associated with Chiesi Farmaceutici S.p.a., where he contributes to the field of pharmaceutical research. Although he has not yet been granted any patents, his work focuses on innovative compounds that may have significant therapeutic applications.
Latest Patent Applications: Ben Paul Whittaker has been involved in several notable patent applications. One of his latest applications is for "Pyrrolidine Derivatives as DDRs Inhibitors." This invention relates to compounds that inhibit Discoidin Domain Receptors (DDR inhibitors), along with methods for preparing these compounds, intermediate compounds useful in such preparations, and pharmaceutical compositions containing them. The therapeutic use of these compounds may be beneficial in treating various disorders associated with DDR mechanisms. Another significant application is for "Tetrahydrothieno Pyridine Derivatives as DDRs Inhibitors." Similar to the previous application, this invention also focuses on compounds that inhibit DDRs and their potential therapeutic uses.
Conclusion: Ben Paul Whittaker is a promising inventor in the pharmaceutical industry, working on innovative solutions that may lead to advancements in medical treatments. His contributions, although not yet reflected in granted patents, show great potential for future developments in the field.